HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lower lipoteichoic and teichoic acid CSF concentrations during treatment of pneumococcal meningitis with non-bacteriolytic antibiotics than with ceftriaxone.

Abstract
In the rabbit model of Streptococcus pneumoniae meningitis, treatment with rifabutin, quinupristin-dalfopristin, moxifloxacin and trovafloxacin led to smaller increases of the CSF concentrations of the pro-inflammatory cell wall components lipoteichoic and teichoic acids (LTA and TA) than did treatment with ceftriaxone. Low doses of moxifloxacin were associated with higher LTA and TA concentrations in CSF than were high doses.
AuthorsK Stuertz, H Schmidt, F Trostdorf, H Eiffert, M Mäder, R Nau
JournalScandinavian journal of infectious diseases (Scand J Infect Dis) Vol. 31 Issue 4 Pg. 367-70 ( 1999) ISSN: 0036-5548 [Print] England
PMID10528875 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Aza Compounds
  • Cephalosporins
  • Fluoroquinolones
  • Lipopolysaccharides
  • Naphthyridines
  • Polysaccharides, Bacterial
  • Quinolines
  • Teichoic Acids
  • Virginiamycin
  • quinupristin-dalfopristin
  • Rifabutin
  • lipoteichoic acid
  • Ceftriaxone
  • trovafloxacin
  • Moxifloxacin
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage)
  • Anti-Infective Agents (administration & dosage)
  • Aza Compounds
  • Ceftriaxone (administration & dosage)
  • Cephalosporins (administration & dosage)
  • Disease Models, Animal
  • Fluoroquinolones
  • Immunoenzyme Techniques
  • Lipopolysaccharides (cerebrospinal fluid)
  • Meningitis, Pneumococcal (cerebrospinal fluid, drug therapy)
  • Moxifloxacin
  • Naphthyridines (administration & dosage)
  • Polysaccharides, Bacterial (cerebrospinal fluid)
  • Quinolines
  • Rabbits
  • Reference Values
  • Rifabutin (administration & dosage)
  • Teichoic Acids (cerebrospinal fluid)
  • Virginiamycin (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: